289 related articles for article (PubMed ID: 15249616)
1. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment.
Amato MP; Bartolozzi ML; Zipoli V; Portaccio E; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Neurology; 2004 Jul; 63(1):89-93. PubMed ID: 15249616
[TBL] [Abstract][Full Text] [Related]
2. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.
Portaccio E; Amato MP; Bartolozzi ML; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
J Neurol Sci; 2006 Jun; 245(1-2):195-9. PubMed ID: 16631794
[TBL] [Abstract][Full Text] [Related]
3. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
[TBL] [Abstract][Full Text] [Related]
4. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
[TBL] [Abstract][Full Text] [Related]
5. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
Rovaris M; Iannucci G; Falautano M; Possa F; Martinelli V; Comi G; Filippi M
J Neurol Sci; 2002 Mar; 195(2):103-9. PubMed ID: 11897239
[TBL] [Abstract][Full Text] [Related]
6. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
De Stefano N; Matthews PM; Filippi M; Agosta F; De Luca M; Bartolozzi ML; Guidi L; Ghezzi A; Montanari E; Cifelli A; Federico A; Smith SM
Neurology; 2003 Apr; 60(7):1157-62. PubMed ID: 12682324
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
8. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
[TBL] [Abstract][Full Text] [Related]
10. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
11. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
12. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
Sánchez MP; Nieto A; Barroso J; Martín V; Hernández MA
Eur J Neurol; 2008 Oct; 15(10):1091-9. PubMed ID: 18727673
[TBL] [Abstract][Full Text] [Related]
13. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
15. Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients' fluency performance in a lateralised manner.
Geisseler O; Pflugshaupt T; Bezzola L; Reuter K; Weller D; Schuknecht B; Brugger P; Linnebank M
Neuroimage Clin; 2016; 10():89-95. PubMed ID: 26759784
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.
Piras MR; Magnano I; Canu ED; Paulus KS; Satta WM; Soddu A; Conti M; Achene A; Solinas G; Aiello I
J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):878-85. PubMed ID: 12810771
[TBL] [Abstract][Full Text] [Related]
17. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
[TBL] [Abstract][Full Text] [Related]
18. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesions.
Rocca MA; De Meo E; Amato MP; Copetti M; Moiola L; Ghezzi A; Veggiotti P; Capra R; Fiorino A; Pippolo L; Pera MC; Falini A; Comi G; Filippi M
Mult Scler; 2015 Jun; 21(7):956-9. PubMed ID: 25392332
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.
Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
Neuroimage; 2006 Apr; 30(3):891-8. PubMed ID: 16360321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]